Jump Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Jump Financial’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14M	Buy	245,390 +241,842	+6,816%	+$13.2M	0.11%	196
2026 Q1	$200K	Sell	3,548 -34,529	-91%	-$2.01M	﹤0.01%	1666
2025 Q4	$2.26M	Sell	38,077 -72,144	-65%	-$3.93M	0.03%	626
2025 Q3	$5.97M	Sell	110,221 -180,996	-62%	-$10.4M	0.07%	357
2025 Q2	$16M	Buy	291,217 +245,017	+530%	+$14.4M	0.17%	134
2025 Q1	$3.27M	Buy	46,200 +41,769	+943%	+$2.81M	0.04%	440
2024 Q4	$291K	Sell	4,431 -15,539	-78%	-$1.04M	0.01%	1317
2024 Q3	$1.4M	Buy	+19,970	New	+$1.67M	0.03%	654
2024 Q2	–	Sell	-3,200	Closed	-$279K	–	1823
2024 Q1	$279K	Buy	3,200 +707	+28%	+$63.3K	0.01%	1481
2023 Q4	$240K	Sell	2,493 -6,366	-72%	-$563K	0.01%	1460
2023 Q3	$784K	Sell	8,859 -60,719	-87%	-$5.4M	0.03%	791
2023 Q2	$6.03M	Buy	+69,578	New	+$6.55M	0.22%	86
2022 Q4	–	Sell	-4,711	Closed	-$400K	–	1588
2022 Q3	$400K	Sell	4,711 -3,365	-42%	-$300K	0.02%	991
2022 Q2	$670K	Sell	8,076 -45,385	-85%	-$3.61M	0.03%	726
2022 Q1	$4.12M	Buy	53,461 +48,813	+1,050%	+$4.08M	0.18%	108
2021 Q4	$411K	Sell	4,648 -16,452	-78%	-$1.36M	0.03%	743
2021 Q3	$1.63M	Buy	+21,100	New	+$1.66M	0.12%	194

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jump Financial's BMRN Position: Q2 2026 in Review

Jump Financial increased its BioMarin Pharmaceuticals (BMRN) stake by 6,816% in Q2 2026, buying an estimated $13.2M and bringing the position to 245,390 shares worth $14M. The position accounts for 0.11% of the portfolio, ranked #196.

Jump Financial first reported a position in BMRN in Q3 2021 and has held it in 17 quarters since. The position peaked at $16M in Q2 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Jump Financial held 245,390 shares of BioMarin Pharmaceuticals worth $14M as of Q2 2026.
Jump Financial bought 241,842 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $13.2M.
BioMarin Pharmaceuticals made up 0.11% of Jump Financial's portfolio in Q2 2026, its #196 holding.
Jump Financial first reported a position in BioMarin Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
Jump Financial's BioMarin Pharmaceuticals position peaked at $16M in Q2 2025.
564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.